Litcius/Paper detail

Interaction between intravenous thrombolysis and clinical outcome between slow and fast progressors undergoing mechanical thrombectomy: a post-hoc analysis of the SWIFT-DIRECT trial

Gaultier Marnat, Johannes Kaesmacher, Lukas Buetikofer, Igor Sibon, Suzana Saleme, Raoul Pop, Hilde Hénon, Patrik Michel, Mikaël Mazighi, Zsolt Kulcsár, Kévin Janot, Paolo Machi, Aleksandra Pikula, Jean‐Christophe Gentric, María Hernández‐Pérez, Lars Udo Krause, Guillaume Turc, David S. Liebeskind, Jan Gralla, Urs Fischer

2023Journal of NeuroInterventional Surgery12 citationsDOIOpen Access PDF

Abstract

BACKGROUND: In proximal occlusions, the effect of reperfusion therapies may differ between slow or fast progressors. We investigated the effect of intravenous thrombolysis (IVT) (with alteplase) plus mechanical thrombectomy (MT) versus thrombectomy alone among slow versus fast stroke progressors. METHODS: The SWIFT-DIRECT trial data were analyzed: 408 patients randomized to IVT+MT or MT alone. Infarct growth speed was defined by the number of points of decay in the initial Alberta Stroke Program Early CT Score (ASPECTS) divided by the onset-to-imaging time. The primary endpoint was 3-month functional independence (modified Rankin scale 0-2). In the primary analysis, the study population was dichotomized into slow and fast progressors using median infarct growth velocity. Secondary analysis was also conducted using quartiles of ASPECTS decay. RESULTS: We included 376 patients: 191 IVT+MT, 185 MT alone; median age 73 years (IQR 65-81); median initial National Institutes of Health Stroke Scale (NIHSS) 17 (IQR 13-20). The median infarct growth velocity was 1.2 points/hour. Overall, we did not observe a significant interaction between the infarct growth speed and the allocation to either randomization group on the odds of favourable outcome (P=0.68). In the IVT+MT group, odds of any intracranial hemorrhage (ICH) were significantly lower in slow progressors (22.8% vs 36.4%; OR 0.52, 95% CI 0.27 to 0.98) and higher among fast progressors (49.4% vs 26.8%; OR 2.62, 95% CI 1.42 to 4.82) (P value for interaction <0.001). Similar results were observed in secondary analyses. CONCLUSION: In this SWIFT-DIRECT subanalysis, we did not find evidence for a significant interaction of the velocity of infarct growth on the odds of favourable outcome according to treatment by MT alone or combined IVT+MT. However, prior IVT was associated with significantly reduced occurrence of any ICH among slow progressors whereas this was increased in fast progressors.

Topics & Concepts

MedicinePost-hoc analysisThrombolysisPost hocSwiftClinical trialEmergency medicineAnesthesiaSurgeryInternal medicineMyocardial infarctionProgramming languageComputer scienceAcute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage ResearchAcute Myocardial Infarction Research